Charles River

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Charles River and other ETFs, options, and stocks.

About CRL

Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions.

CEO

Birgit Girshick

CEOBirgit Girshick

Employees

19,700

Employees19,700

Headquarters

Wilmington, Massachusetts

HeadquartersWilmington, Massachusetts

Founded

1947

Founded1947

Employees

19,700

Employees19,700

CRL Key Statistics

Market cap

14.13B

Market cap14.13B

Price-Earnings ratio

-60.84

Price-Earnings ratio-60.84

Dividend yield

—

Dividend yield—

Average volume

967.23K

Average volume967.23K

High today

$298.50

High today$298.50

Low today

$290.73

Low today$290.73

Open price

$298.50

Open price$298.50

Volume

48.38K

Volume48.38K

52 Week high

$299.32

52 Week high$299.32

52 Week low

$144.26

52 Week low$144.26

Stock Snapshot

The current Charles River(CRL) stock price is $296.05, with a market capitalization of 14.13B. The stock trades at a price-to-earnings (P/E) ratio of -60.84.

As of 2026-08-24, Charles River(CRL) stock has fluctuated between $290.73 and $298.50. The current price stands at $296.05, placing the stock +1.8% above today's low and -0.8% off the high.

Charles River(CRL) shares are trading with a volume of 48.38K, against a daily average of 967.23K.

In the last year, Charles River(CRL) shares hit a 52-week high of $299.32 and a 52-week low of $144.26.

CRL News

Simply Wall St 1d

Is Charles River Quietly Redefining Its Edge Through Complex Biologics and Vaccine Testing?

Earlier this week, Medigen Vaccine Biologics announced it is partnering with Charles River Laboratories International to characterize and validate the virus see...

Simply Wall St 3d

What Does Charles River Laboratories International Gain From This Vaccine Collaboration?

Charles River Laboratories International (NYSE:CRL) and Medigen Vaccine Biologics Corp. announced a collaboration to advance a next generation multivalent enter...

TipRanks 3d

Insider Move at Charles River Labs: Director Cashes In on Company Stock

New insider activity at Charles River Labs ( (CRL) ) has taken place on August 20, 2026. Summer Sale - Claim 70% Off TipRanks Unlock powerful investing tools wi...

Analyst ratings

78%

of 18 ratings

Buy

77.8%

Hold

16.7%

Sell

5.6%

More CRL News

TipRanks 4d

Charles River, Medigen Vaccine to advance new vaccine development programs

Charles River (CRL) Laboratories International and Medigen Vaccine Biologics collaborate on the characterization and validation of the virus seed bank for MVC’s...

Simply Wall St 5d

Charles River Laboratories International Cut 2026 Guidance, Is The Stock Still 11% Undervalued?

Charles River Laboratories International (CRL) cut its 2026 earnings guidance after reporting a second quarter net loss and slightly lower revenue. The company...

People also own

Based on the portfolios of people who own CRL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.